These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2693323)

  • 41. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gonadotrophin hormone-releasing hormone analogue treatment of fibroids.
    Shaw RW
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):245-68. PubMed ID: 10023421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathological changes in leiomyomata treated with leuprolide acetate.
    Upadhyaya NB; Doody MC; Googe PB
    Fertil Steril; 1990 Nov; 54(5):811-4. PubMed ID: 2121550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The estimation of LHRH receptors in the tissue of human leiomyoma, myometrium and endometrium].
    Marinaccio M; Reshkin S; Pinto V; Paradiso A
    Minerva Ginecol; 1994 Oct; 46(10):519-26. PubMed ID: 7838406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Uterine myoma: hormonal therapy--conventional hysterectomy].
    Lang N
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():6-8. PubMed ID: 8118360
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of intrauterine and large pedunculated subserosal leiomyomata with sequential uterine artery embolization and myomectomy.
    Paxton BE; Lee JM; Kim HS
    J Vasc Interv Radiol; 2006 Dec; 17(12):1947-50. PubMed ID: 17185691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
    Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of the evidence for treatment of leiomyomata.
    Olive DL
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():841-3. PubMed ID: 11035992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical decision making regarding leiomyomata: what we need in the next millenium.
    Haney AF
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():835-9. PubMed ID: 11035991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laparoscopic approaches to uterine leiomyomas.
    Milad MP; Sankpal RS
    Clin Obstet Gynecol; 2001 Jun; 44(2):401-11. PubMed ID: 11345001
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of fibroids.
    Altchek A
    Curr Opin Obstet Gynecol; 1992 Jun; 4(3):463-71. PubMed ID: 1535799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Surgical treatment of subserosal fibroids: the cons].
    Marret H; Ouldamer L
    Gynecol Obstet Fertil; 2011; 39(7-8):454-7. PubMed ID: 21752689
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma].
    Scheer ML; Slebos DJ; Bogchelman DH; Timens W
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma.
    Abulafia O; Kleinhaus K; Levi G; Lee YC; Sherer DM
    Gynecol Obstet Invest; 2001; 52(2):108-13. PubMed ID: 11586038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical and socioeconomic impact of uterine fibroids.
    Greenberg MD; Kazamel TI
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):625-36. PubMed ID: 8786874
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
    Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
    Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New approaches to the management of fibroids.
    Olive DL
    Obstet Gynecol Clin North Am; 2000 Sep; 27(3):669-75. PubMed ID: 10958011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of uterine leiomyomata by LH-RH agonists.
    Blumenfeld Z
    Recent Results Cancer Res; 1992; 124():19-31. PubMed ID: 1615216
    [No Abstract]   [Full Text] [Related]  

  • 60. ACOG criteria set. Gonadotropin-releasing hormone agonists for preoperative treatment of leiomyomata. American College of Obstetricians and Gynecologists Committee on Quality Assessment.
    Int J Gynaecol Obstet; 1996 Feb; 52(2):213-4. PubMed ID: 8855113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.